Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
2021
2020
Europe
Clear all
Type of publications
NITAG documentation
(93)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(2)
Topics
Available to download in languages
Regions
Europe
(96)
Africa
(20)
Americas
(129)
Eastern Mediterranean
(1)
South-East Asia
(4)
Western Pacific
(36)
Countries
Belgium
(18)
Denmark
(2)
France
(21)
Germany
(8)
Ireland
(7)
Netherlands
(7)
Spain
(1)
Sweden
(3)
United Kingdom
(27)
Diseases
COVID-19
(93)
Pneumococcal disease
(3)
Ebola
(3)
Hepatitis B
(1)
Human papillomavirus (HPV)
(6)
Influenza
(9)
Measles
(1)
Rotavirus
(1)
Tuberculosis
(2)
Typhoid
(1)
Varicella
(2)
Yellow fever
(1)
Vaccine topics
Acceptance
(1)
Coverage
(2)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(2)
All age groups
(1)
Healthcare workers
(1)
Older adults
(2)
Pregnant women
(1)
Risk group
(2)
Publication date
2021
(77)
2020
(19)
2024
(2)
2023
(18)
2022
(37)
2019
(2)
2018
(4)
2017
(3)
2016
(3)
2015
(4)
2014
(2)
2013
(2)
2011
(2)
2010
(2)
2006
(1)
2005
(1)
96 results found
2021
∙
JCVI
Use of the AstraZeneca COVID-19 (AZD1222) vaccine: updated JCVI statement, 7 May 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 in pregnant and breastfeeding women
2021
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Vaccination of people with a history of Covid-19
2021
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - AstraZeneca vaccine
2021
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19 - Janssen COVID-19 vaccine
2021
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - the Moderna Covid-19 mRNA (nucleoside modified) vaccine
2021
Vaccination strategy against COVID19 in Spain
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
2020
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Sars-Cov-2 vaccination strategy - Preliminary recommendations on the strategy for prioritizing populations to be vaccinated
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register